Re:Cognition Health is acknowledged as a leading UK independent provider of cognitive health services. We provide early, accurate, diagnosis and treatment of cognitive disorders affecting individuals, of all ages, suffering from cognitive impairment as a consequence of a wide range of clinical conditions. Re:Cognition Health’s clinical trials centres in London, Guildford and Plymouth, offer thos
e, who are clinically eligible, early access to new medications designed to slow down or halt progression of MCI, mild and moderate memory loss due to Alzheimer’s Disease
Our patients choose us because we are highly patient-centric, collaborative and effective, providing the most accurate diagnosis available and access to new and emerging treatments. Re:Cognition Health’s Birmingham centre is on schedule to open in summer 2017.
24/04/2026
Changes in memory, concentration or behaviour are sometimes dismissed as a normal part of ageing.
However, persistent cognitive changes may be a sign that further evaluation could be helpful.
Early assessment allows specialists to understand what may be happening and guide patients and families toward the right support and care.
23/04/2026
Constant exposure to negative news online, sometimes called doomscrolling, can affect emotional wellbeing.
Taking breaks from social media, limiting news consumption and choosing trusted information sources can help support healthier digital habits.
Small changes in how we engage with information can have a positive impact on both mental and cognitive health.
We’re proud to share that Re:Cognition Health USA has successfully renewed its GCSA Certified Site Status with the International Accrediting Organization for Clinical Research (IAOCR).
This recognition reflects the consistently high standards our clinical trials teams uphold, and our ongoing commitment to continuous improvement in research, patient care, and operational excellence.
At Re:Cognition Health, quality is not a one-time achievement — it is embedded in everything we do. From delivering world-class clinical trials to supporting patients and their families, our teams remain focused on advancing research that has the potential to transform lives.
As Mostafa Hassan, MBBCh, Director of Clinical Trials, USA, shared:
“We remain mindful that our participants are contributing greatly to trials that could potentially impact the lives of millions of people, and we are committed to providing our participants and their families with world-class care. This GCSA certification represents far more than documentation; it reflects the team’s daily professionalism, integrity, patient-centered focus, and operational excellence.”
We are grateful to our dedicated teams and to the participants who make this work possible.
15/04/2026
ADHD does not always present in obvious ways. For many people, difficulties show up through emotional overwhelm, inconsistent focus, planning challenges, or disrupted sleep.
Acknowledging these subtler experiences helps create more accurate assessment, informed care, and better support across different stages of life.
14/04/2026
Many factors influence brain health over time.
Research suggests that regular movement, good sleep, balanced nutrition and mental stimulation can support cognitive wellbeing.
While lifestyle habits cannot prevent every neurological condition, they can still play an important role in maintaining overall brain health.
The Bio-Hermes-002 study is helping move Alzheimer’s diagnosis towards earlier, more accessible identification through blood-based biomarkers.
By focusing on inclusive research and real-world application, studies like this are laying the groundwork for earlier intervention and improved care pathways worldwide.
A major study found that people who stay mentally active throughout life have a lower risk of developing dementia. Activities such as reading, writing, and learning languages were linked to up to a 40% lower risk of Alzheimer’s disease and mild cognitive impairment.
Lifelong mental stimulation was also associated with a later onset of dementia, highlighting its role in long-term brain health.
Autism acceptance focuses on understanding, inclusion, and recognising individual strengths and differences.
Listening, learning, and creating supportive environments help people on the autism spectrum feel respected and understood across all stages of life.
01/04/2026
The impact of trauma does not always end with physical recovery. Blast injuries can be followed by psychological effects that influence mood, memory, sleep, and daily functioning.
Improving recognition and diagnosis of PTSD helps ensure individuals receive the care and support they need to recover and move forward.
Neurodiversity recognises that there is no single way for a brain to think, learn, or process the world.
Autism and ADHD are part of natural neurological variation. Accurate assessment, understanding, and appropriate support help individuals thrive at every stage of life.
Neurodiversity Celebration Week encourages awareness, inclusion, and informed care.
18/03/2026
ADHD is often associated with inattention or hyperactivity, but many challenges are less visible.
Difficulties with emotional regulation, time perception, executive functioning, and sleep can significantly affect daily life. Recognising these hidden symptoms supports clearer understanding, accurate assessment, and access to the right support.
Brain Awareness Week focuses on increasing understanding of how the brain works and how neurological and cognitive conditions develop.
Advances in neuroscience research and diagnostics help provide clearer answers, support earlier identification, and guide more personalised care for patients and families.
Greater understanding of the brain leads to better outcomes across the lifespan.
Be the first to know and let us send you an email when Re:Cognition Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Re:Cognition Health specialise in the diagnosis, treatment and care of people experiencing cognitive and mental health concerns.
The Re:Cognition Health UK clinics in London, Guildford, Plymouth and Birmingham are global-leaders in clinical trial patient recruitment. The team are united by a shared vision to change the future of Alzheimer’s research by providing early access to new treatments for the disease, at no cost.
Re:Cognition Health’s first clinic in the USA opened in February 2018 in Fairfax, VA. The US team are committed to raising awareness of the opportunity for members of the local community to access disease-modifying treatments for Alzheimer’s disease, as part of a ground-breaking clinical trial.
The specialist mental health services provided at Re:Cognition Health’s Harley Street Medical Area Clinic include: ADHD assessments for children and adults, autism assessments, diagnostic and rehabilitation services for patients with mild traumatic brain injury and world-leading memory services.
Re:Cognition Health’s clinics are home to a range of brain & mind experts, including: Neurologists, Neuropsychiatrists, Neuroradiologists, Neuropsychologists, Speech & Language Therapists, Child & Adolescent Psychiatrists, Psychologists, Psychiatrists, Nutritionists and Physiotherapists.